Ignite Creation Date:
2024-05-06 @ 8:09 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06278285
Status:
RECRUITING
Last Update Posted:
2024-03-18
First Post:
2024-02-09
Brief Title:
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery
Sponsor:
Centre Hospitalier Universitaire de Nice
Organization:
Centre Hospitalier Universitaire de Nice
Study Overview
Official Title:
Effect of Agonist GLP1 on Adipose Tissue in Patients Undergoing Bariatric Surgery
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Maigrir_OT
Brief Summary:
Normalizing weight gain and preventing the redistribution of body fat is a major health issue and could help prevent the onset of various symptoms of metabolic syndrome Above all it is important to understand the mechanisms by which these different treatments affect adipose tissue To this end the investigators will first study the impact of GLP-1 analogues on adipose tissue The main objective is to show that subjects treated with a GLP-1 agonist have a significant change in their oxytocin levels compared with subjects not treated with a GLP-1 agonist
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None